have a relatively higher degree of stent recoil than metal does. Hence, we hereby intended to develop novel composite bioresorbable stents (cBRSs) made of poly(p-dioxanone) (PPDO) and polycaprolactone with mechanically reinforced compression performance for pediatric patients.
Objective: Rates of cardiovascular and diabetes-related complications are generally decreasing. Whether a similar decline has occurred with lower extremity amputations remains poorly characterized. The aim of this study was to examine secular trends in the rate of lower extremity amputations among patients with diabetes and peripheral artery disease (PAD) within a single-payer regional health care system.
Methods: The study cohort included all individuals $40 years old who underwent diabetes or PAD-related lower limb amputation in Ontario, Canada (population, 13.6 million) between April 2005 and March 2016. Patients and amputations were identified through deterministic linkage of administrative health databases including inpatient and outpatient records. Quarterly rates (per 100,000 individuals $40 years old) of minor or major amputation as well as of major amputation alone were established. Time-series analyses were conducted using exponential smoothing models to characterize secular trends.
Results: A total of 19,961 patients underwent minor or major lower extremity amputations, of whom 12,755 (64%) underwent a major amputation. A total of 18,745 (94%) patients had PAD; 16,366 (82%) had diabetes; and 15,150 (76%) had both PAD and diabetes. The rate of any amputation initially declined between 2005 Q2 and 2010 Q4 but increased again by 2016 Q1 (Fig 1) , with PAD-related minor or major amputations following a similar trend (Fig 1) . A significant increase was observed in the rate of any amputation among patients with diabetes and those with diabetes and PAD (Fig 1) . Whereas the rates of major amputations decreased, albeit not significantly, among PAD patients, diabetes-related major amputations did not decrease (Fig 2) .
Conclusions: Diabetes-related lower extremity amputations have increased during the last decade. These data support renewed efforts to prevent and to decrease the burden of limb loss among patients with diabetes. Objective: Peripheral artery disease (PAD) is caused by atherosclerosis of the lower extremities. Almost 5% of patients with PAD progress to the advanced stage, critical limb ischemia (CLI). Patients with CLI are at a significant risk of major limb amputation and death. Therefore, there is an immense requirement for the early diagnosis and management of CLI. Several studies suggest that microRNAs (miRNAs), small noncoding ribonucleic acids, can be used as biomarkers of chronic diseases, such as heart failure and diabetes. We hypothesize that miRNA can be used as a diagnostic biomarker for PAD and CLI.
Methods: To address our objectives, we built a biobank of 1200 PAD and non-PAD patients. We stratified patients on the basis of their clinical history, claudication distance, and ankle-brachial index into non-PAD, moderate PAD, severe PAD, and CLI. In each group, 20 patients were matched by their age, sex, and cardiovascular risk factors. For each group, we purified and sequenced the circulating plasma miRNA using miRNA columns and next-generation RNA sequencing. While comparing non-PAD with PAD patients, we considered miRNA with a P value of < .05 and at least 1.5-fold change as significantly expressed miRNA.
Results: We identified 876 miRNAs in plasma. Of these, 46 miRNAs are differentially expressed (19 miRNAs are upregulated and 27 are downregulated) in PAD patients relative to non-PAD patients. After searching existing miRNA databases, we identified 16 novel miRNAs that are associated only with PAD. Our in-depth analysis identified hsa-miR-3909 and hsa-miR-483-5p as potential markers for CLI.
Conclusions: For the first time, we identified novel and known miRNAs that can be used as biomarkers for CLI. Future studies looking at the gene targets of these miRNAs are currently being investigated at our laboratory.
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Methods: The Montreal Cognitive Assessment (MoCA) was administered preoperatively to elective vascular surgery patients to assess cognitive function. POD was identified using the Confusion Assessment Method and chart and psychiatrist confirmation review. Demographic information, medications, substance abuse, psychiatric disorders, and previous delirium were prospectively recorded. Vascular surgery patients (elective and emergency) retrospectively provided cost information related to sitter use and length of stay related to delirium alone, dementia alone, and delirium and dementia.
Results: There were 174 patients enrolled (72.9% male; age, 69.9 6 11 years); 119 (68.8%) had MoCA scores <24, indicating cognitive impairment, with 7.5% having severe impairment (dementia). POD incidence was 12%. MoCA scores were lower in those who underwent amputation (15.9 of 30; P < . 000) Objective: Stents are often used to maintain the vessel's restored diameter during or after endovascular treatment for different diseases, such as iliac vein stenosis causing the post-thrombotic syndrome. To improve the success of the treatment, we need to understand the stent's deformation characteristics (foreshortening, compliance, radial pressure, and collapse). These important factors contribute to each 
